Geoff Dusheiko
Kings College Hospital, United Kingdom
After earning his MBBS degree from the University of Witwatersrand in Johannesburg, South Africa, he completed his internship and residency in Johannesburg. His fellowships were conducted at the Johannesburg Hospital Liver Unit and the National Institutes of Health, Maryland, and the University of Minnesota, USA.
His research interests include the management and treatment of HCV and HBV and small hepatocellular carcinoma; he has a special interest in research on viral hepatitis, especially viral genotyping, applied molecular virology, the natural history of chronic viral hepatitis and antiviral therapies. A member of several organisations, including EASL, AASLD and IASL, Professor Dusheiko is also a Fellow of the Royal College of Physicians, the Royal College of Physicians of South Africa, and the Royal College of Physicians of Edinburgh.
He previously served as Educational Councilor on the Governing Board of EASL for 4 years and was the recipient of the EASL Recognition Award in 2014. An advisor for the UK National Institute of Health and Care Excellence, he was a Director of the Skipton Fund, a UK ex gratia payment scheme for patients infected with HCV through contaminated blood products. He served as interim Director of the Blood Safety, HIV, viral hepatitis and STI Division of Public Health England in 2019. He serves as an advisor to the National Medical Research Council, Singapore, the TherVacB Consortium (European Horizon Grant) and the A-Tango Consortium (EUH2020 grant) and on WHO guideline groups. He is a co-editor of Alimentary Pharmacology and Therapeutics, and has previously served on editorial boards for the Journal of Viral Hepatitis, Hepatology, Best Practice & Research Clinical Gastroenterology, and Gut among others. Professor Dusheiko has authored or co-authored more than 500 articles in international peer-reviewed journals or books.